A B S T R A C T The dynamics of CO2 exchange in the lungs of man was studied by observing the rate of disappearance of a stable isotope of CO2 ('3C02) from the alveolar gas during breath holding. Over 50%o of the inspired isotope disappeared within the first 3 sec followed by a moderately rapid logarithmic decline in which one-half of the remaining 13CO2 disappeared every 10 sec.
The large initial disappearance of 13CO2 indicated that alveolar 13CO2 equilibrated in less than 3 sec with the CO2 stored in the pulmonary tissues and capillary blood. The volume of CO2 in the pulmonary tissues calculated from this initial disappearance was 200 ml or 0.33 ml of CO2 per milliliter of pulmonary tissue volume.
The alveolar to end-capillary gradient for 13CO2 was calculated by comparing the simultaneous disappearance rates of "3CO2 and acetylene. At rest and during exercise this gradient for 13CO2 was INTRODUCTION Carbon dioxide is present in the blood and tissues of the lungs in the form of physically dissolved CO2, bicarbonate, carbonic acid, and protein complexes (2). Chinard, Enns, and Nolan studied the interaction of these forms of CO2 and the alveolar gas in the dog by injecting radioactive bicarbonate (H14C03-) and carbon dioxide (14CO2) into the pulmonary artery (3, 4) . They concluded that the interconversion of the various forms of The Journal of Clinical Investigation Volume 47 1968 CO2 is so rapid that the expired CO2 may be considered to come from one large common CO2 pool. Similar conclusions were reached by Feisal, Sackner, and DuBois who injected bicarbonate into the pulmonary artery of the dog and measured the evolution of CO2 in the alveoli with a sensitive body plethysmograph (5) . These investigators as well as others have found that inhibition of the enzyme carbonic anhydrase modified the exchange of CO2 between blood, pulmonary tissues, and alveolar gas sufficiently to produce a significant alveolar to end-capillary CO2 gradient (A-C CO2 gradient) (6) (7) (8) .
By measuring the rate of uptake of a stable carbon dioxide isotope (13CO2) from the alveolar gas during breath holding, we have developed a new technique for studying the interrelationships of the various forms of CO2 and the A-C CO2 gradient in the lungs of man. Measurements of the uptake of isotopic CO2 have the advantage that they can provide the greatest possible A-C CO2 gradient for a given total alveolar CO2 tension, pulmonary capillary blood flow, and diffusing capacity. From the data it was possible to estimate the A-C CO2 gradient and the diffusing capacity of the lungs for CO2, and to determine the size of the CO2 spaces in the lungs, the CO2 dissociation curve of the lung tissues, the mean hydrogen ion concentration of the pulmonary tissues, and the relative contribution of bicarbonate to total CO2 in the lungs.
METHODS
If a subject inspires a breath of a gas mixture containing CO2 which has been enriched with the stable carbon isotope of mass 13 (23CO2), the distribution of the isotope within the lungs is likely to be governed by factors similar to those reported to influence the disappearance of soluble inert gases such as nitrous oxide and acetylene (9) . There should be a rapid disappearance of the isotope initially because of its movement into the pulmonary parenchymal tissue volume (Vti,) and pulmonary capillary blood volume (Vc), followed by a more gradual disappearance as it is carried away by the blood flowing through the pulmonary capillaries. If the highly insoluble inert gas, neon, is added to the inspired mixture, the effect of dilution of the isotope in the lung's residual air can be taken into account. If acetylene (C2H2), whose rate of disappearance during breath holding is a function of pulmonary capillary blood flow (Qc), is included in the inspired mixture, it is possible to evaluate the influence of Qc on the rate of disappearance of 13CO2 (9) . The CO2 content of the pulmonary parenchymal tissue (Vti,) and Vc can be determined from the initial rapid disappearance of 13CO2. The alveolar to end-capillary gradient for CO2 can be calculated by comparing the rates of disappearance of C2H2 and 13CO2. Once this gradient is known, the diffusing capacity for CO2 (DLcO2) can be determined. The relative contribution of bicarbonate to total CO2 transport can be evaluated by making measurements before and after the administration of a carbonic anhydrase inhibitor.
Experimental procedure. 13C02 was prepared by adding hydrochloric acid to barium carbonate enriched 10-fold or more with carbon atoms of mass 13. 1 The experiments were conducted in the following manner: a rapidly responding mass spectrometer was tuned to the mass 44 peak in order to measure 12CO2, and the instrument's inlet tube was attached to a mouthpiece through which the subject first blew out to residual volume. He then began rebreathing for three to six breaths from an unheated rubber anesthesia bag containing approximately 2 liters of 7-12% C02, 0-12% oxygen, and balance nitrogen. In the early experiments the per cent of 02 in the rebreathing bag and inspired mixture was 21%. Because under these conditions the 02 saturation of the blood increased from about 75-98% on entering the pulmonary capillaries, the Pco2 would be expected to be slightly higher in the capillary blood than in the mixed venous blood (Haldane effect). In order to minimize this difference between mixed venous Pco2 and capillary blood Pco2 in the later experiments, we made the capillary 02 saturation similar to the mixed venous level by using no 02 in the rebreathing bag and by reducing the 02 concentration in the inspired mixture to 5%.
The concentration and volume of C02 in the rebreathing bag was chosen so that after several breaths, the output of the mass spectrometer became constant indicating that the partial pressure of CO2 (Pco2) in the subject's alveolar volume (VA) and the rebreathing bag were at the virtual mixed venous Pco2 (10) (Fig. 1) . The subject then exhaled to his residual volume and maximally inspired a gas mixture containing a total Pco2 approximately equal to the virtual mixed venous Pco2, 0.6-1.0% 3CO2, 0.4% CO, 0.5% neon, 0.75% C2H2, 5 or 21% 02, and balance nitrogen. After breath holding for about 10 sec, he forcefully expired. Note that the concentration of CO2 in the rebreathing bag and the inspired mixture were chosen so that during breath holding the Pco2 in the blood entering the capillaries was similar to the Pco2 in VA. As a result the total Pco2 and CO2 content in the pulmonary capillaries and alveoli remained relatively constant during the breath holding period. The first liter of the expirate was discarded in order to wash out the respiratory dead space, and the remaining gas was collected for analysis. The procedure was repeated after intervals of an hour for breath holding periods of approximately 3, 7, and 14 sec. Breath holding periods longer than 14 sec were avoided because of the possibility of recirculation of the isotope. (Table I) . At the start of the experiment the natural occurrence of the isotope, defined as the concentration of the isotope divided by the total concentration of CO2 in the specimen, was determined from a sample of the subject's expired air.
, and (carbon monoxide] of the gas samples were measured on a gas chromatograph. Alveolar PcO2 during breath holding was determined from either the continuous mass spectrometer record of expired breath or by analyzing the contents of the rebreathing bag. Alveolar volume (VA) during breath holding was measured by adding the inspired volume recorded on a spirometer to the residual volume which had been determined previously by the closed circuit helium method (12) . The disappearance from the alveoli of C2H2, carbon monoxide (CO), and 13CO2 in excess of virtual mixed venous 13CO2 (*CO2) were plotted on semilogarithmic graph paper against time (Fig. 2) . From the C2H2 disappearance, pulmonary capillary blood flow (Qc) and pulmonary parenchymal tissue volume (Vti.) were determined (9) . Carbon monoxide diffusing capacity (DLco) was calculated from the disappearance of CO (13) . In practice it was found to be convenient to calculate the per cent disappearance of *CO2 by the following formula whose derivation is given in detail elsewhere (14 P1s3CO2 ---natural occurrence of '3CO2 (1) Pi,.05 and Pico2 are the partial pressures of neon and C02, respectively, in the test gas mixture which is to be inspired, PE..., and PECo2 are the partial pressures of neon and C02, respectively, in the expired gas sample, PI'aCO2 and PE13CO2 are the partial pressures of 13CO2 in the inspired test gas mixture and the expired gas mixture, and the natural occurrence of 13CO2 is the fraction [E3CO2]/[total C02] measured from the subject's expired air before inhaling gas mixtures enriched with 13CO2.
Calculation of the CO2 content of the lung's tissues ( Vti.) from the rate of disappearance of labeled C02. Theoretical analyses indicate that a soluble inert gas equilibrates extremely rapidly (in less than 1 sec) with the finer parenchymal tissues of the lung (9) , and that the initial disappearance of such a gas can be used to calculate the pulmonary parenchymal tissue volume (Vti8). Experimentally the logarithm of alveolar inert gas concentration is plotted against time of breath holding and the curve extrapolated to time zero (see line for C2H2 in Fig. 2 ). Any rapid initial solution of inert gas in the lung tissue will be seen as a depression of the intercept with respect to the zero time axis, and will depend on the relative volumes of lung tissue and alveolar gas, as well as the partition coefficient of the inert gas. In the case of *CO2, while a small amount will physically dissolve in the lung tissues (Vti5) a larger amount will exchange with the bicarbonate contained in V ,, and the pulmonary capillary blood volume (Vc) (3). An additional Note that the fraction P*cO2t-b + P*co2t-. equals the amount of *C02 present in the alveoli, determined by extrapolating the rate of disappearance of *C02 during breath holding back to time zero, divided by the amount of *CO2 predicted to be present from the neon dilution (Fig. 2) . This fraction therefore equals *C02 intercept in per cent + 100 and equation 2 (15) and the CO2 content of the subject's blood at PAcO2 (see below), and then subtracting the product of these two terms from the C02 content of Vti. + Vc. In these experiments the CO2 content of the pulmonary capillary blood during breath holding was determined indirectly from measurements of Pco2 and Po2 in the rebreathing bag or the expired sample. These values were then used to obtain the CO2 content from a standard CO2 dissociation curve (16) . In two of the subjects the CO2 content and Pco2 of a blood specimen drawn from the antecubital vein were measured by the Astrup technique (17) and this value was then adjusted to the CO2 content at PAcO2 by using the nomograms published by Bartels and coworkers (18) .
Calculation of pulmonary capillary blood flow (ac) from the rate of disappearance of *CO2. If there is no alveolar to end-capillary gradient (A-C CO2 gradient) for CO2, the rate of disappearance of *CO2 from the alveolar gas during breath holding will be flow limited. Then Qc calculated from the disappearance of *C02 should be equal to values obtained with an inert gas such as C2H2. As a means of verifying the presence or absence of a significant A-c C02 gradient, we compared in our subjects Qc measured by the C2H2 breath holding method with Qc determined from the rate of disappearance of *C02. Qc using *CO2 was determined in the following manner: the instantaneous rate of change of the concentration of *C02 in the lungs after inspiration of the test gas and after equilibration of *C02 with lung tissue and capillary blood must equal the amount which is being removed by (6) where PA*CO21 equals the PA*CO2 in mm Hg at the end of breath holding and tBH is the breath holding time in minutes.
Determination of the slope of the C02 dissociation curve of the pulmonary tissues. Techniques for the determination of the CO2 dissociation curve of the lung tissues have included a plethysmographic method (19) , direct measurement of the CO2 content in vitro after equilibration with known concentrations of CO2 (20) , and methods based on the collection of alveolar gas samples after varying breath holding periods (21, 22) . In this study a modification of the breath holding methods described by DuBois (21) and Fenn and Dejours (22) was used. The method is described in Appendix I.
Calculation of the diffusing capacity of lungs for CO2--(DLCo2). While normally it is believed there is little or no end-capillary gradient for CO2 between the alveolar gas, the plasma, and the red blood cells in the pulmonary endcapillary blood, Chinard and coworkers (3) and Soni, Feisal, and DuBois (23) have shown that after the administration of a carbonic anhydrase inhibitor, a significant gradient between alveolar Pco2 and the Pco2 in the endcapillary blood is present due to the slower conversion of bicarbonate to molecular Co2. If a measureable gradient is produced, the diffusing capacity of the lungs for CO2 (IDLco2) could be calculated from the rate of disappearance of *C02 during breath holding by a method identical with that recently described for O2 using a stable 02 isotope (14) . Constantine, Craw, and Forster (24) (15) .
RESULTS
Measurement of rate of disappearance of *CO2
in five resting subjects. Analysis of the gas samples collected after the shortest period of breath holding, which was about 2.5 sec, showed that over half of the *CO2 had disappeared from the alveolar gas (Tables II and III (Table III) .
CO2 content of lung tissue. The mean amount of CO2 present in the lungs of the five subjects determined from the initial rapid loss of *CO2 from the alveoli was 244 ml STPD (Table IV) The line of least squares for each gas was determined from the four points resulting from four separate breath holding periods. The extension of the lines from the 3 sec points to time zero is an extrapolation. The depressed intercepts at time zero result from the initial uptake of the gases by the pulmonary capillary blood (Vc) and pulmonary tissues (Vti.) (see text). breath holding after inspiring *CO. Twvo additional points were obtained by multiple breath holding maneuvers after inspiring air or 12-15% CO2 (Table V) . Fig. 4 shows the CO2 dissociation curve of VtI alone. The data for this figure was determined by subtracting the volume of CO2 calculated to be in Vc from the volume in Vti, + Vc. 4 Since the mean figure for our subjects is two to 4Assuming that the CO2 solubility in Vti, is the same as in water (0.57-ml STPD per ml per atmosphere), the change in CO2 content for each millimeter change in Pco2 in a subject with Vti5 equal to 600 ml would be: (0.57 X 600)/760 or 0.45 ml/mm Hg. consumption was 1250'ml/min, and the respiratory quotient was 0.91. Compared to resting measurements in the same subject the initial rapid disappearance of *CO2 and C2H2 showed little change, but the fall in the concentration of these gases during subsequent breath holding doubled (Tables   III B / and IV B and Fig. 5 ). Qc calculated from the rate of disappearance of the two gases was 12.0 and 12.6 liters/min for *CO2 and C2H2, respectively. This similarity in blood flows suggested that even a doubling of the cardiac output is not associated with an alveolar to end-capillary CO2 gradient of any significance.
Effect of body position. Because of the possibility that uneven distribution of ventilation and volume with respect to perfusion (uneven VA/Qc and uneven VA/Qc) might influence the rate of disappearance of *CO2, measurements were made in both the sitting and supine positions as well as during exercise (Table III) . Neither body position nor exercise were found to produce any consistent differences in the calculated CO2 content of the lung tissues, relative disappearance rates of *CO2 and C2H2, or other parameters. Therefore, the different degrees of uneven VA/Qc and VA/Qc very likely produced by exercise and by varying body position did not appear to alter appreciably the factors determining the rate of disappearance of *CO, from the alveoli.
Measurements after the administration of a carbonic anhydrase inhibitor (acetazolamide). One subject (RWH), over a 15 min interval, received an intravenous infusion of 500 ml of 5% glucose and water containing 7 g of sodium aceta- (27) . The difference in symptoms may be related to the rapid infusion of the drug within 15 min in the present study compared to the administration over a 1-8 hr period in the experiments reported by Janowitz and coworkers. During intoxication with acetazolamide QC2H2 was 10.9 liters/min and *CO2 disappeared at a rate of 6.3%/sec so that Q*co2 was only 3.01 liters/min. The CO2 stores in Vti. + Vc calculated from the initial disappearance of the isotope were only 69 ml (Tables III C and IV C and Fig. 6 ). Without enzyme inhibition at this QC2H2 the subject would be expected to have a *CO2 disappearance rate of 23%/sec and CO2 stores in VtI + Vc equal to 313 ml. Since the lower values observed after the administration of acetazolamide are most likely due to the decreased ability of *CO2 to exchange with the bicarbonate in VtI8 and Vc, the difference between the above observed and predicted values of CO2 in Vti. + Vc must represent CO2 in the form of bicarbonate. In this subject I Kindly supplied by Dr. R. N. Fallon, Lederle Laboratories as the sodium salt of Diamox acetazolamide. the fraction of total CO2 in the form of bicarbonate calculated by this method was 79% for Vtiu and 73% for Vc (Table VIII) . Because only the conversion of *CO2 to bicarbonate inhibited by acetazolamide was taken into account by this calculation, these percentages are minimal values. The above findings support the view that the carbonic anhydrase in lung tissues and blood is necessary in order to have equilibration of the CO2 stores in Vti., Vc, and alveolar gas during the time it takes blood to traverse the pulmonary capillaries (3, 5 (Fig. 2) there was little change in the zero intercepts but subsequent disappearance was twice as fast. FIGURE 6 Graph showing the rate of disappearance of C2H2 and *CO2 from the lungs of subject RWH after the administration of the carbonic anhydrase inhibitor acetazolamide. The heavy dashed line represents the rate of disappearance of *COa predicted on the basis that there was no alveolar to end-capillary gradient or alveolar to pulmonary tissue gradient for *COa. Since the experimental line had a higher value at zero time and a less steep slope, equilibration between C02 in blood, lung tissue, and alveolar gas was not present during enzyme inhibition.
Calculation of hydrogen ion concentration (H+)
in Vtu. If Pco, for 4-6 hr.
The diffusing capacity for CO2 (DLCO2). In the presence of active carbonic anhydrase, the pulmonary capillary blood flows calculated from the rate of disappearance of *CO2 and C2H2 were almost identical. This finding indicates that on the average there is an extremely small alveolar endcapillary gradient for *CO2 so that DLCO2 cannot be measured accurately. For example in two subjects (WFR and MAF) the solution for DLCO2 produced an imaginary number because Q*co2 was actually greater than Qc2H2. In the other subjects the value at rest was over 200 ml/(min X mm Hg) but slight errors in the rate of disappearance of *CO2 or C2H2 would produce large changes in DLco0.
After the administration of acetazolamide, endcapillary P*co2 calculated by previously described methods (14) was less than one-third of the alveolar P*co2 and the resulting DrcO2 was only 42 ml/ (min x mm Hg). Because of the large alveolar to end-capillary gradient DLCO2 in this special circumstance can be measured with reasonable precision. For example, a 3%o error in QC2H2 produces less than a 1 % change in DLC02. The reduction in DLCo2 during carbonic anhydrase inhibition is most likely due to a fall in Oco2, the diffusing capacity of the blood for CO2, which has been shown in vitro to decrease markedly after the administration of acetazolamide. According to this hypothesis, the P*co2 in the blood in the capillary would most certainly have equilibrated with that in the alveolar gas long before the end of the capillary, but would not be in equilibrium with the blood bicarbonate, either within or without the red cell. Using equation 7 the value for Oco2 which would account for the DLCO2 of 42 ml/ (min x mm Hg) in this subject can be calculated in the following manner: according to equation 7: 1/42 = 1/DMCo2 + 1/(6 X 130) where 130 represents an estimate of Vc during carbonic anhydrase inhibition in this subject in ml (Tables III and IV) . According to Table III DLCo2, which must be less than DMC02, is at least five times greater than 42, if indeed it is not so large it cannot be measured by this technique at all. Therefore, the term 1/DMco2 becomes so small it can be neglected, giving 0 = 0.32 ml/(min X mm Hg X ml). This in vivo value is considerably smaller than the in vitro value of 0.6 ml (min X mm) reported by Constantine, Craw, and Forster (24) .
This discrepancy may be related to the fact that a significant part of the initial reaction these authors measured during carbonic anhydrase inhibition was due to the formation of carbamate superimposed on the slower formation of bicarcarbonate. If Oco2 is calculated from their data collected after the first 100 msec of the reaction, at which time the carbamate reaction has likely gone to completion, Oco2 is only 0.24 ml/ (min X mm Hg) per ml, a figure in better agreement with the value measured in vivo. However it is likely that during carbonic anhydrase inhibition Oco2 varies along the length of the capillary. Large values would be expected at times when carbamate concentrations are changing and small values when only bicarbonate levels are varying. Because Oco2 may at times be a variable quantity, the present in vivo value as well as the reported in vitro values measured during carbonic anhydrase inhibition should be considered as approximations.
DISCUSSION
Estimate of size of DLCO2 and the alveolarcapillary CO2 gradients due to diffusion in normal subjects. In these experiments at the start of the capillary after inspiring '3CO2, the alveolar P13co2 was 5-10-fold greater than the P13co2 in the virtual mixed venous blood. In contrast during resting ventilation the difference between unlabeled alveolar Pco2 and mixed venous Pco2 is only about 20%. Despite this ability of isotopic CO2 to magnify any difference between alveolar and endcapillary Pco2, in our subjects no consistent gradient was detected and DLCO2 could not be calculated accurately. Since we estimate that the analytical methods permit the detection of a difference of 5 % between alveolar and end-capillary P13co2, only a minimal value for DLCO2 can be calculated based on the assumption of an alveolar to end-capillary gradient of this size. In the five subjects at rest this minimal value for DLCo2 was 220 (SD = 30) ml/(min X mm Hg). The minimal value for the diffusing capacity of the pulmonary membrane (DMCO2) determined from the minimal value of DLco2, a value of Oco2 equal to 5.1 ml/ (min X mm Hg x ml) (24) , and equation 7 was 464 (SD = 165) ml/(min X mm Hg). This value is approximately one-third the value for DMC02 predicted on the basis of measurements of the diffusing capacity of the pulmonary membrane for CO (DMco), the molecular weights of CO and *CO2, and the relative solubilities of CO and CO2 in water. 7 Because 7 If it is assumed that DMco equals 60 ml/(min X mm Hg), DMCo2 would equal 60 X (0.592/0.0185)(-428/45) or 1500 ml/(min X mm Hg). 28 Time course of the fall in capillary Pco2 as blood traverses the pulmonary capillaries. Curve A is a plot for a normal subject at rest calculated using a minimal valve for DLCO2 derived from the rate of disappearance of *CO2 from the alveolar gas. The broken curve below curve A was calculated using a value for DLCO2 derived from the size of the carbon monoxide diffusing capacity (see text). Alveolar and capillary Pco2 are essentially in equilibrium in 0.4 sec. Curve B is a plot for a normal subject after the administration of acetazolamide calculated on the basis that the inhibitor reduced the diffusing capacity for CO2 from 250 to 40 ml/(min X mm Hg) and alveolar Pco2 remained at 40 mm Hg. Under these conditions an alveolar to end-capillary gradient for CO2 of 4 mm Hg would be present. Curve C describes the time course along the capillary during carbonic anhydrase inhibition predicted to take piace in a subject with a pulmonary disease which had reduced the capillary blood volume and diffusing capacity of the pulmonary membrane to one-third of normal and in addition prevented him from decreasing his alveolar Pco2 below 40 mm Hg. Under these conditions DLCO2 would be only 10.8 ml/(min X mm Hg) and in order to have a sufficient alveolar-capillary CO2 gradient for elimination of the body's CO2 production, mixed venous Pco2 would have to increase to 70.5 mm Hg. The alveolar to end-capillary CO2 gradient would be 23.5 mm Hg. The following dimensions of the capillary bed and lungs representative for our subjects were used in these calculations, namely: alveolar Pco2 = 40 mm Hg; CO2 production = 288-ml STPD per minute; Qc = 7200 ml/min; slope of CO2 dissociation curve = 0.0057 ml STPD per milliliter per mm Hg; minimal DLCO2 = 250 ml/(min X mm Hg); DLcO2 calculated from measurements of DLco = 435 ml/(min X mm Hg); and Vc = 100 ml. Oco2 was assumed normally to be 5.1 ml/ (min X mm Hg) per ml and 0.35 ml/(min X mm Hg) per ml during carbonic anhydrase inhibition. Capillary transit time calculated from the relationship Vc . Qc, equalled 0.83 sec in the normal subject and 0.28 sec in the hypothetical subject with pulmonary disease.
determined on the basis of the following two assumptions. First, according to the molecular weights of CO and *CO2 and their relative solubilities in water, DMC02 is 25-fold greater than DMco. Second, Vc for CO2 may be larger than Vc for CO but recent measurements of 02 vs. ether exchanges between the pulmonary vessels and the alveolar gas imply that this difference can be at the most 20% (31 (33) . Figure 8 order to improve arterial blood oxygenation and lower the arterial Pco2 (34, 35) . The rationale of this therapy has been disputed (36) . In order to evaluate the effect of carbonic anhydrase inhibition in CO2 elimination in the presence of severe pulmonary disease, we calculated the capillary Pco2 for a hypothetical subject who was unable to lower his alveolar Pco2 below 40 mm Hg, and who, in addition, had values for DMCo2 and Vc one-third of normal (Figure 8 curve C) . Pulmonary capillary blood flow does not usually decrease strikingly in pulmonary disease so that the capillary transit time equal to Vc/Qc is considerably reduced. Under these conditions during severe carbonic anhydrase inhibition a steady state for CO2 elimination would not be reached until the end-capillary Pco2 had risen from 40.3 to 63 mm Hg, a rise large enough to have significant physiological and clinical consequences. Since some patients with pulmonary disease cannot hyperventilate in order to compensate for the less efficient pulmonary elimination of CO2 secondary to carbonic anhydrase inhibition, it is not surprising that occasionally symptoms suggestive of increased acidosis and clinical deterioration may accompany therapy with these drugs (35, case 10, 37). However, clinically much smaller doses of acetazolamide are administered than were used in this study so that the increase in the alveolar to end-capillary CO2 gradient in patients is likely to be negligible or at least considerably smaller than the large gradient calculated to have developed in this hypothetical patient. While carbonic anhydrase inhibitors may cause hyperventilation and thereby lower the arterial and alveolar Pco2 in many patients, even in normal subjects modest amounts of these agents are known to impair CO2 elimination (38) .
Validity of the measurement of hydrogen ion concentration in lung tissue. Intracellular electrodes, indicators, and the dissociation of weak bases and acids (39) (40) (41) have all been used to measure intracellular pH. In this study the lung pH was measured by the third technique using the bicarbonate and carbonic acid system. This method, which was first used by Warburg in 1922 (41) has given discordant values because of the difficulty in measuring intracellular bicarbonate levels. For example, in rat muscle the acid-labile CO2 fraction is almost twice as large as the barium soluble fraction, which suggests that significant amounts of intracellular CO2 may be present in nonbicarbonate fractions such as CO2 protein complexes (42) . In the present study we measured the total CO2 in the lungs that exchanges with alveolar gas in a second or less before and after carbonic anhydrase inhibition and assumed that the difference must be the total bicarbonate in the lungs.
This method has several limitations and sources of error. First, the method is only applicable to a tissue such as the lungs where very rapid exchange of labeled CO2 facilitated by carbonic anhydrase takes place (4). Second, if carbonic anhydrase inhibition is incomplete, the bicarbonate fraction will be underestimated. Fortunately in this study, 80% of the CO2 exchange was blocked by the inhibitor, and since 9%o of the CO2 exchange could be assigned to dissolved CO2, the error due to incomplete inhibition could not exceed 11%o of the total CO2 space. Third, carbonic anhydrase inhibition may produce a change in the bicarbonate and intracellular nonbicarbonate bound CO2. We have no way to evaluate this source of error except to point out that several hours after the administration of a carbonic anhydrase inhibitor, the CO2 content of blood changes only slightly (7) . Fourth, the toxic effects during carbonic anhydrase inhibition were severe enough in one human to make us reluctant to administer large doses of the inhibitor to others, and, therefore, we have data on only one subject. Fifth, evidence has been recently presented in vitro that carbonic anhydrase, in addition to catalyzing the conversion of CO2 to bicarbonate, directly facilitates the transport of molecular CO2 (43, 44) . If this action of carbonic anhydrase is of significance in vivo, the CO2 exchange space in the lungs blocked by carbonic anhydrase inhibition might be greater than the bicarbonate space. This would produce an underestimation of the hydrogen ion concentration. However, diffusion distances in the lung parenchyma are generally so small, that a carrier enzyme could not appreciably increase the size of the CO2 space. Sixth, the concentration of CO2 in the lungs that is neither bicarbonate nor dissolved CO2 may vary widely among individuals and may be influenced by acetazolamide.
Since none of the above limitations to this method of determining tissue pH appear insurmountable, we believe it deserves further evaluation and refinement in the experimental animal and isolated tissue preparations. Dimensions and dynamics of CO2 stores in the lungs of man. The data presented above support the findings of a number of investigators (3) (4) (5) , that the various forms of carbon dioxide present in the lungs exchange so rapidly, that the alveolar Pco2 can be considered to come from one common CO2 pool. Representative figures for an adult human with a resting lung volume of 3000-ml STPD at an alveolar Pco2 of 40 mm Hg are: 150 ml of CO2 in the alveolar gas, 200 ml of CO2 in the pulmonary tissue (Vti.), and 50 ml of CO2 in the capillary blood (Vc). At least 70% of the CO2 in Vc and VtI is in the form of bicarbonate. In the subjects in this study a change in alveolar Pco2 of 1 mm Hg was accompanied by the movement of about 2 ml of CO2 into or out of Vti and Vc.
Calculations made by DuBois, Britt, and Fenn (45) have demonstrated the considerable ability of the CO, stores in Vti5 and Vc to buffer changes in alveolar Pco2. They showed that this buffering action of Vti8 and Vc reduces the predicted variation in alveolar Pco2 during the respiratory cycle in resting man from about 3 to 2 mm Hg. The CO2 stores in Vti8 and Vc must also buffer oscillations in alveolar Pco, secondary to the pulsatile nature of the pulmonary capillary blood flow. We estimate that this change in our subjects is in the order of 0.13 mm Hg between diastole and systole.
Without this buffering capacity of Vti8 and Vc this figure would be 0.18 mm Hg. Bosman, 'Lee, and Marshall have also presented evidence for this buffering mechanism for CO2 during the cardiac cycle from measurements of instantaneous carbon dioxide exchange in the lungs using a body plethysmograph (30) .
Individual variation of the CO2 content and shape of the CO2 dissociation curve of lung tissue. The five subjects in this study showed considerable differences in the CO2 content of their lung tissue and the slope of its CO2 dissociation curve which could not be explained by error in the method or difference in body size. For example the CO2 content of Vtir + Vc at an alveolar Pco2 of 45 mm Hg varied from 104 ml/m2 of surface area in subject MAF to 164 ml/m2 in RWH. This is a determination with an experimental error which we believe is less than 20%o of the measurement. Other investigators using different techniques have also noted similar variations in these quantities (19, 20) . Therefore, the pulmonary intracellular CO2 concentration most likely has a wider range of normal values than observed in plasma.
Validity of calculating CO2 content of pulmonary capillary blood from alveolar PCO2 during breath holding. Recently several investigators have reported that virtual mixed venous Pco2 obtained by rebreathing is greater than the mixed venous Pco2 measured from samples of pulmonary arterial blood even when pulmonary arterial and alveolar Po2 are the same (47, 48) . The effect of this interesting finding on the pulmonary capillary CO2 content which was required in this study for the calculation of QCCO2 and the alveolar endcapillary CO2 gradient, has not been clarified at the present time. Fortunately the shape of the CO2 dissociation curve for blood is such that changes in Pco2 produce proportionally less changes in CO2 content. For example a 10%o elevation in the rebreathing Pco2, which is the approximate magnitude suggested by these reports, will at most produce an overestimation of capillary CO2 content of 4% and would give the false impression that alveolar P*co2 was 4% greater than end-capillary P*co2. This source of error is therefore small enough not to alter the conclusions reached in this study.
APPENDIX I
Method for the determination of the slope of the CO2 dissociation curve of the pulmonary tissues. The subject rebreathed several breaths from a 2 liter bag containing 8% CO2 in order to make alveolar Pco2 equal to virtual mixed venous Pco2(PMvCo2). He then maximally inspired a breath of room air, held his breath for 3 sec, and then delivered an alveolar gas sample. Pco2 of the expired gas sample was determined from the output of the continuously recording mass spectrometer. Every 15 min the procedure was repeated until three to six determinations of Pco2 had been made with time of breath holding varying from 2 to 14 sec. During breath holding CO2 will leave Vti8 and Vc, enter the alveoli, and a new equilibrium between Pco2 in the alveolar gas, Vc and Vti8 will be reached at a Pco2 lower than PMvco2 (21, 22) . This equilibration takes place in less than 1-2 sec and the amount of CO2 entering the alveoli will be a function of the CO2 dissociation curves of Vti. and Vc (5, 19) . The CO2 contained in the residual volume (RV), Vti., and Vc before inspiration plus any C02 contained in the inspired gas will equal the CO2 contained in the alveolar volume, Vti. 
